OA11369A - Process for thepreparation of azacycloalkylalkanoyl pseudotetrapeptides. - Google Patents

Process for thepreparation of azacycloalkylalkanoyl pseudotetrapeptides. Download PDF

Info

Publication number
OA11369A
OA11369A OA1200000096A OA1200000096A OA11369A OA 11369 A OA11369 A OA 11369A OA 1200000096 A OA1200000096 A OA 1200000096A OA 1200000096 A OA1200000096 A OA 1200000096A OA 11369 A OA11369 A OA 11369A
Authority
OA
OAPI
Prior art keywords
acid
protecting group
formula
alkyl
mixture
Prior art date
Application number
OA1200000096A
Other languages
English (en)
Inventor
Christophe Daubie
Netto Geoffrey A D
Patrick Leon
James J Mencel
Benoit J Vanasse
Michel Lavigne
Robert C Liu
Robert Stammler
Original Assignee
Aventis Pharm Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharm Prod Inc filed Critical Aventis Pharm Prod Inc
Publication of OA11369A publication Critical patent/OA11369A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • C07K5/06113Asp- or Asn-amino acid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
OA1200000096A 1997-10-10 2000-03-31 Process for thepreparation of azacycloalkylalkanoyl pseudotetrapeptides. OA11369A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6171997P 1997-10-10 1997-10-10

Publications (1)

Publication Number Publication Date
OA11369A true OA11369A (en) 2004-01-27

Family

ID=22037674

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200000096A OA11369A (en) 1997-10-10 2000-03-31 Process for thepreparation of azacycloalkylalkanoyl pseudotetrapeptides.

Country Status (18)

Country Link
US (1) US6180759B1 (ru)
EP (1) EP1030831A4 (ru)
JP (1) JP2001519411A (ru)
KR (1) KR20010024467A (ru)
CN (1) CN1278791A (ru)
AP (1) AP1057A (ru)
AU (1) AU738114B2 (ru)
BG (1) BG104408A (ru)
BR (1) BR9814068A (ru)
CA (1) CA2306823A1 (ru)
EA (1) EA002724B1 (ru)
HU (1) HUP0003788A3 (ru)
IL (1) IL135553A0 (ru)
NO (1) NO20001793D0 (ru)
OA (1) OA11369A (ru)
PL (1) PL340915A1 (ru)
SK (1) SK4332000A3 (ru)
ZA (1) ZA989241B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9711340A (pt) * 1996-08-21 1999-08-17 Rhone Poulenc Rorer Pharma Composto composi-Æo farmac-utica e processo para preparar um composto
CN100422147C (zh) * 2002-11-01 2008-10-01 北京天衡药物研究院 一种制备0-取代磺酰酪氨酸类化合物的方法
KR100841409B1 (ko) * 2003-12-16 2008-06-25 에스케이케미칼주식회사 암로디핀 겐티세이트 염과 이의 제조방법
CN103254265B (zh) * 2012-02-21 2016-07-13 上海希迈医药科技有限公司 醋酸阿比特龙三氟乙酸盐及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042487A (en) * 1964-06-25 1966-09-14 Ici Ltd Polypeptide derivatives
JPS6322081A (ja) * 1986-07-11 1988-01-29 Kissei Pharmaceut Co Ltd 新規なアミノ酸誘導体
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives
IE902238A1 (en) * 1989-06-30 1991-01-16 Abbott Lab Tetrapeptide type-b cck receptor ligands
IE914334A1 (en) * 1990-12-17 1992-06-17 Black James Foundation Tetrapeptide derivatives and analogues
JP3032297B2 (ja) * 1993-10-15 2000-04-10 ローヌ‐プーラン ローラー ファーマシューティカルズ インコーポレイテッド 抗血栓性アザシクロアルキルアルカノイルペプチド及びプソイドペプチド
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
GB9516994D0 (en) * 1995-08-18 1995-10-18 Iaf Biochem Int Solution synthesis of peripheral acting analgestic opioid tetrapeptides
EP0768384B1 (en) * 1995-10-11 2001-06-13 Holland Sweetener Company V.o.F. Improved enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester
BR9711340A (pt) * 1996-08-21 1999-08-17 Rhone Poulenc Rorer Pharma Composto composi-Æo farmac-utica e processo para preparar um composto
NL1005808C2 (nl) * 1997-04-14 1998-10-19 Dsm Nv Hexahydro-aspartaamamiden en werkwijze voor de bereiding ervan.

Also Published As

Publication number Publication date
AP2000001781A0 (en) 2000-06-30
US6180759B1 (en) 2001-01-30
EA002724B1 (ru) 2002-08-29
BG104408A (bg) 2000-12-29
NO20001793L (no) 2000-04-06
HUP0003788A2 (hu) 2001-04-28
EP1030831A4 (en) 2003-01-02
SK4332000A3 (en) 2000-12-11
EA200000399A1 (ru) 2000-10-30
CA2306823A1 (en) 1999-04-22
HUP0003788A3 (en) 2001-05-28
PL340915A1 (en) 2001-03-12
IL135553A0 (en) 2001-05-20
AU738114B2 (en) 2001-09-06
AU1074699A (en) 1999-05-03
EP1030831A1 (en) 2000-08-30
ZA989241B (en) 1999-06-04
KR20010024467A (ko) 2001-03-26
BR9814068A (pt) 2000-09-26
CN1278791A (zh) 2001-01-03
JP2001519411A (ja) 2001-10-23
NO20001793D0 (no) 2000-04-06
AP1057A (en) 2002-04-08

Similar Documents

Publication Publication Date Title
KR870000372B1 (ko) 아실트리펩타이드의 제조방법
CZ129694A3 (en) Novel peptide derivatives
WO1997012903A1 (en) Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins
JP4171423B2 (ja) 高純度ペリンドプリルの調製方法および合成に有用な中間体
CA2301969A1 (en) Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
CA2212356A1 (en) Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
OA11369A (en) Process for thepreparation of azacycloalkylalkanoyl pseudotetrapeptides.
HU200783B (en) Process for producing peptide-substituted heterocyclic compounds having immunostimulating action and pharmaceutical compositions comprising same
EP0159396B1 (en) Carboxyalkyl peptide derivatives
JPH0647599B2 (ja) ヘプタノイル―Glu―Asp―Ala―アミノ酸系免疫賦活薬
US4767743A (en) Peptide immunostimulants
HU220875B1 (en) Pentapeptide derivative, production thereof and their intermediates
EP0227306B1 (en) Peptide immunostimulants
KR900004648B1 (ko) 펩타이드 유도체의 제조방법
WO1999019294A1 (en) Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
CZ2003165A3 (cs) Způsob přípravy solí 5-fenylpentanoyl-(S)-alanyl-(S)-arginyl-(S)-alanyl-{(S)-2-[(R)-3-amino-2-oxopyrrolidin-1-yl]propionyl}-(S)-alanyl-(S)-arginyl-(S)-alanyl-4-aminofenylacetamidu
MXPA00003470A (es) Procedimientos para preparar azacicloalquilalcanoil pseudotetrapeptidos
JPH0597789A (ja) α−ヒドロキシグリシンアミド誘導体及びその製造方法
CZ20001296A3 (cs) Způsob přípravy azacykloalkylalkanoylpseudotetrapeptidů
JPH0339077B2 (ru)
JP4050238B2 (ja) Kpvトリペプチドジアミド誘導体の改良された合成方法
KR20010077201A (ko) 4-하이드록실아미노-3-사이클로부텐-1,2-다이온 유도체 및이들의 제조 방법
JPH0925293A (ja) ヒスチジル−ヒドロキサム酸誘導体
JPH0339078B2 (ru)